Ramtin Agah - Jan 26, 2024 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director
Signature
/s/ Ramtin Agah
Stock symbol
RNXT
Transactions as of
Jan 26, 2024
Transactions value $
$0
Form type
4
Date filed
1/30/2024, 07:33 PM
Previous filing
Jan 23, 2024
Next filing
Apr 9, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNXT Common Stock Purchase +41K +632.75% 47.5K Jan 26, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNXT Warrants Purchase +41K 41K Jan 26, 2024 Common Stock 41K $1.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. These warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029.